Skip to content

Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?

Molecular Detection of SARS-CoV-2 From Oropharyngeal Swabs Performed With or Without Specimen Collection From the Palatine Tonsils - a Multicenter Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05611203
Enrollment
1000
Registered
2022-11-09
Start date
2022-11-10
Completion date
2023-03-02
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus, Corona Virus Infection, SARS-CoV Infection

Brief summary

Citizens who undergo testing for COVID-19 at one of two Testcenters in Copenhagen Captial Region will be invited to participate in the study. The participants will be randomized to either an oropharyngeal swap including the palatine tonsils OR an oropharyngeal swap without the palatine tonsils for SARS-CoV-2 testing. The swabs will be sent to the clinical microbiology laboratory for SARS-CoV-2 detection using RT-PCR. The diagnostic accuracy and SARS-CoV-2 viral load will be compared. The participants will be asked to complete a questionnaire regarding their symptoms.

Detailed description

We will include citizens referred for outpatient testing for COVID-19 who will be offered to participante in the study on a volunteer basis. Participants are all volunteers, who are attending the test facilities to obtain a PCR test. Participants are required to provide oral and written informed consent to participate before entering the study. The inclusion criterion is 18 years or more of age. Exclusion criteria are neck breathers (tracheostomy/laryngectomy patients). The participants will be randomized to either an oropharyngeal swap including the palatine tonsils OR an oropharyngeal swap without the palatine tonsils for SARS-CoV-2 testing. The swabs will be sent to the clinical microbiology laboratory for SARS-CoV-2 detection using RT-PCR as usual. The diagnostic accuracy and SARS-CoV-2 viral load will be compared using independent t-test. The participants will be asked to complete a questionnaire regarding their symptoms and the number of sick days. All data will be documented on-site in a secure web database (REDCap). The primary outcome will be reported as: • SARS-CoV-2 RNA by RT-PCR test result (positive, negative, inconclusive) The secondary outcome will be reported as: * SARS-CoV-2 RT-PCR cycle threshold (Ct) value * Test discomfort on a 11-point NRS-scale * Development of COVID-19 disease after testing * SARS-CoV-2 detection rate for each healthcare worker * Mallampati Score of participants being tested

Interventions

PROCEDUREAn Oropharyngeal swab

An Oropharyngeal swab performed for diagnostic purposes

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* citizens referred for outpatient testing for COVID-19 in Valby and Hillerød COVID-19 TestCenter.

Exclusion criteria

* Age under 18 years * neck breathers (tracheostomy/laryngectomy patients)

Design outcomes

Primary

MeasureTime frameDescription
RT-PCR resultsDay 1The detection rate of SARS-CoV-2 RNA

Secondary

MeasureTime frameDescription
Inconclusive testsDay 1Number of inconclusive RT-PCR tests results
Test discomfortDay 1Self reported on a 11-point NRS-scale from 0 - 10 (with 10 being the worst imaginable discomfort)
Sycle threshold (Ct)Day 1SARS-CoV-2 RT-PCR cycle threshold (Ct) values
Test accuracy between healthcare workersDay 1SARS-CoV-2 detection rate for each healthcare worker
Participants oropharynx anatomyDay 1Mallampati Score of participants
Development of COVID-19 disease after testing1 monthOnline questionare about symptoms send by email

Countries

Denmark

Contacts

Primary ContactTobias Todsen, MD, PhD
tobias.todsen@regionh.dk+45 35466008

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026